Código QR (código de barras bidimensional)

Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

ABSTRACTObjectives In the absence of head-to-head comparisons across relapsed/refractory multiple myeloma (RRMM) treatments following the approval of the oral proteasome inhibitor ixazomib, in combination with lenalidomide and dexamethasone (IRd), we conducted an indirect comparison of the efficacy...

ver descrição completa

Na minha lista:
Principais autores: Maral DerSarkissian, Holly Cranmer, Jonathan Dabora, Iryna Bocharova, Dasha Cherepanov, Mu Cheng, Rachel H. Bhak, Mei Sheng Duh
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2023-12-01
coleção:Hematology
Assuntos:
Network meta-analysis
systematic literature review
relapsed/refractory multiple myeloma
ixazomib
lenalidomide
dexamethasone
Acesso em linha:https://www.tandfonline.com/doi/10.1080/16078454.2022.2156731
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados